Financials

  • Market Capitalization 4.52 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
51.34
Relación precio/flujo de caja
6.56

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1361
CRSP
CRISPR Therapeutics AG - Common Shares
50.46 USD-0.34%-13.80%-4.25%-5.58%4.87 B USD
1377
LEGN
Legend Biotech Corporation - American Depositary Shares
25.67 USD-0.31%-6.69%-26.68%-19.73%4.75 B USD
1426
VKTX
Viking Therapeutics, Inc. - Common Stock
37.97 USD-0.39%-9.29%+28.71%+21.50%4.41 B USD
1436
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.49 USD-0.04%-2.52%+19.50%+15.44%4.36 B USD

Noticias